Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ease of Use, Ease of Learning, and Convenience of the CagriSema Dual-Chamber Pen: Results From a Usability Study in Adults With Overweight, Obesity, or Type 2 Diabetes.

Journal of diabetes science and technology·2026
Same author

Predicting late radiation-associated neurocognitive and endocrine toxicity in patients with brain tumors.

Journal of neuro-oncology·2026
Same author

Placenta Percreta Treated by Uterine Artery Embolization, with Fatal Outcome: A Case Report.

Journal of vascular and interventional radiology : JVIR·2026
Same author

Expectation as a Risk for Covid-19-Related Olfactory Changes: Observations From the California Farmworkers Health Survey.

Risk analysis : an official publication of the Society for Risk Analysis·2026
Same author

Long-term tumor control after Gamma Knife radiosurgery for sporadic vestibular schwannoma.

Journal of neurosurgery·2026
Same author

Abemaciclib in meningiomas with somatic NF2 or CDK pathway alterations: the phase 2 Alliance A071401 trial.

Nature medicine·2026

Related Experiment Video

Updated: Mar 26, 2026

Visualizing Genetic Variants, Short Targets, and Point Mutations in the Morphological Tissue Context with an RNA In Situ Hybridization Assay
10:57

Visualizing Genetic Variants, Short Targets, and Point Mutations in the Morphological Tissue Context with an RNA In Situ Hybridization Assay

Published on: August 14, 2018

11.3K

The Cobas® EGFR Mutation Test v2 assay.

Paul Brown1

  • 1Roche Molecular Diagnostics, 4300 Hacienda Drive, Pleasanton, CA 94588, USA.

Future Oncology (London, England)
|February 4, 2016
PubMed
Summary

Paul Brown, a leader in molecular diagnostics and pharmaceuticals, transitioned from drug discovery to business roles, managing key brands like Tamiflu® and Xenical.

Area of Science:

  • Pharmaceutical Sciences
  • Organic Chemistry
  • Business Administration

Background:

  • Paul Brown's career trajectory at Roche Diagnostics Corporation and Roche Pharma.
  • His early research in organic chemistry and post-doctoral work at Caltech.
  • Progression through various leadership roles within the pharmaceutical industry.
Keywords:
Cobas® EGFR Mutation Test v2in vitro diagnosticslung canceroncology

More Related Videos

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

12.4K
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.8K

Related Experiment Videos

Last Updated: Mar 26, 2026

Visualizing Genetic Variants, Short Targets, and Point Mutations in the Morphological Tissue Context with an RNA In Situ Hybridization Assay
10:57

Visualizing Genetic Variants, Short Targets, and Point Mutations in the Morphological Tissue Context with an RNA In Situ Hybridization Assay

Published on: August 14, 2018

11.3K
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

12.4K
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.8K